181 related articles for article (PubMed ID: 7010560)
1. Protective effect of immunization with Salmonella minnesota Re 595 against ascending Escherichia coli O6K13H1 pyelonephritis in rats.
Larsson P; Kaijser B; Baltzer IM; Olling S
Scand J Infect Dis Suppl; 1980; Suppl 24():220-3. PubMed ID: 7010560
[TBL] [Abstract][Full Text] [Related]
2. The effect of active immunisation on ascending pyelonephritis in the rat.
Radford NJ; Chick S; Ling R; Coles GA; Asscher AW
J Pathol; 1974 Mar; 112(3):169-75. PubMed ID: 4601025
[No Abstract] [Full Text] [Related]
3. Protection against experimental pyelonephritis by antibodies to pili.
Silverblatt FJ; Weinstein R; Rene P
Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
[TBL] [Abstract][Full Text] [Related]
4. Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.
Kaijser B; Larsson P; Olling S
Infect Immun; 1978 Apr; 20(1):78-81. PubMed ID: 352939
[TBL] [Abstract][Full Text] [Related]
5. Passive protection against heterologous gram-negative bacteria mediated by antiserum to epimeraseless Rc mutant of Salmonella minnesota.
Konstantinov G; Karacholeva M; Eskenazy M; Ivanova R; Vassileva J; Naumova F; Tekelieva R; Strahilov D
Ann Immunol (Paris); 1982; 133D(1):71-6. PubMed ID: 6760795
[TBL] [Abstract][Full Text] [Related]
6. Consequences of active or passive immunization of turkeys against Escherichia coli O78.
Arp LH
Avian Dis; 1980; 24(4):808-15. PubMed ID: 7023456
[TBL] [Abstract][Full Text] [Related]
7. [Effect of immunization with Escherichia coli J5 on the course of experimental pyelonephritis in rats].
Straube E; Naumann G; Broschewitz U
Z Urol Nephrol; 1988 Apr; 81(4):247-55. PubMed ID: 3041706
[TBL] [Abstract][Full Text] [Related]
8. Antipili antibody affords protection against experimental ascending pyelonephritis.
Silverblatt FJ; Cohen LS
J Clin Invest; 1979 Jul; 64(1):333-6. PubMed ID: 376560
[TBL] [Abstract][Full Text] [Related]
9. Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli.
Mattsby-Baltzer I; Hanson LA; Olling S; Kaijser B
Infect Immun; 1982 Feb; 35(2):647-53. PubMed ID: 7035370
[TBL] [Abstract][Full Text] [Related]
10. Immunoprotection of guinea pigs against experimental acute pyelonephritis after the administration of Escherichia coli purified fimbriae.
Dima VF; Petrovici A; Dima SV; Petrovici M; Burghelea B
Arch Roum Pathol Exp Microbiol; 1989; 48(3):215-25. PubMed ID: 2577515
[TBL] [Abstract][Full Text] [Related]
11. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
[TBL] [Abstract][Full Text] [Related]
12. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
Brooks SJ; Lyons JM; Braude AI
Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
[TBL] [Abstract][Full Text] [Related]
13. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
[TBL] [Abstract][Full Text] [Related]
14. Experimental Escherichia coli 06 infection in mice. II. Protective factors of immunity after immunosuppression.
Ahlstedt S
Scand J Infect Dis Suppl; 1980; Suppl 24():216-9. PubMed ID: 7010558
[TBL] [Abstract][Full Text] [Related]
15. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
[TBL] [Abstract][Full Text] [Related]
16. Protection against acute, ascending pyelonephritis caused by Escherichia coli in rats, using isolated capsular antigen conjugated to bovine serum albumin.
Kaijser B; Larsson P; Olling S; Schneerson R
Infect Immun; 1983 Jan; 39(1):142-6. PubMed ID: 6337094
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary results of the vaccine treatment of chronic pyelonephritis in animal experiments].
Straube E; Broschewitz U; Schill H; Naumann G
Z Urol Nephrol; 1984 Jul; 77(7):401-5. PubMed ID: 6385543
[TBL] [Abstract][Full Text] [Related]
18. Lack of protection against ascending Escherichia coli pyelonephritis in diabetic rats following immunization with purified lipopolysaccharide.
Bryan LE; Schollaardt T; Pak CY; Kim CJ; Yoon JW
Can J Microbiol; 1986 Dec; 32(12):967-9. PubMed ID: 3545411
[TBL] [Abstract][Full Text] [Related]
19. [Local autovaccine treatment of experimental urinary tract infections in the rat].
Straube E; Broschewitz U
Z Urol Nephrol; 1988 Jan; 81(1):1-12. PubMed ID: 3284238
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
